Indian equities may be better placed to deliver steady returns from here, with valuations turning supportive after a sharp correction, according to BofA Securities.Arvind...
After nearly two years of correction in pharmaceutical stocks, valuations across the sector have turned more reasonable, prompting Elara Securities to turn constructive on...